Skip to main content
Dr. Lal Pathlabs Limited logo

Dr. Lal Pathlabs Limited — Investor Relations & Filings

Ticker · LALPATHLAB ISIN · INE600L01024 LEI · 984500E8E9CY102B9718 BSE.NS Human health and social work activities
Open in API
Filings indexed 1,098 across all filing types
Latest filing 2021-01-29 Regulatory Filings
Country IN India
Listing BSE.NS LALPATHLAB

About Dr. Lal Pathlabs Limited

https://www.lalpathlabs.com/

Dr. Lal Pathlabs Limited is a provider of diagnostic and related healthcare tests and services. The company offers a comprehensive range of clinical laboratory tests and profiles used for prediction, early detection, diagnostic screening, confirmation, and monitoring of diseases. Its service portfolio encompasses pathology, including biochemistry, hematology, clinical pathology, histopathology, and molecular diagnostics, as well as radiology services such as X-ray, ultrasound, and CT scans. The organization operates an extensive network of laboratories, patient service centers, and pick-up points, utilizing advanced automated systems and standardized processes. Key offerings include specialized wellness packages and home sample collection. The company maintains high quality standards through international and national accreditations, serving a diverse patient base and healthcare providers with a focus on accuracy and timely reporting.

Recent filings

Filing Released Lang Actions
Financial Result Updates
Regulatory Filings
2021-01-29 English
Analysts/Institutional Investor Meet/Con. Call Updates
Call Transcript Classification · 95% confidence The document is an invitation and intimation of a conference call for investors and analysts regarding the Q3 and 9 months financial results for FY21 of Dr. Lal PathLabs Limited. It mentions the date and time of the call, the management participants, and instructions for joining the call. There is no actual financial data or detailed financial report included in the text. The document is clearly an announcement of a conference call related to earnings, not the earnings release itself or the transcript. Therefore, the document fits the category of a Call Transcript (CT) invitation or announcement. However, since it is only the invitation and not the transcript, the best fitting category is Call Transcript (CT) as it relates to the conference call content. Confidence is high as the document explicitly states it is a conference call invitation for discussing earnings.
2021-01-21 English
Copy of Newspaper Publication
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding the publication of a newspaper advertisement about a Board Meeting scheduled for January 29, 2021. The meeting will consider approval of unaudited financial results for the quarter and nine months ended December 31, 2020, and a proposal for a 2nd interim dividend. The document itself is a notification of the advertisement and meeting, not the financial results or dividend declaration report. The document length is short (1710 characters) and it references a notice rather than containing substantive financial data or the actual report. Therefore, it fits best as a Regulatory Filing (RNS) since it is a compliance disclosure under SEBI Listing Regulations and does not contain the financial report itself or detailed financial data.
2021-01-19 English
Board Meeting — Financial Results/Dividend
Regulatory Filings Classification · 95% confidence The document is a notice of a Board Meeting scheduled to consider and approve unaudited financial results for a quarter and nine months period, as well as a proposal for an interim dividend. It references Regulation 29 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, which pertains to disclosures related to board meetings. The document is short (1625 characters) and serves as an announcement of an upcoming board meeting rather than containing actual financial results or detailed reports. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a Regulatory Filing (RNS) announcing the board meeting and its agenda.
2021-01-18 English
Certificate under SEBI (Depositories and Participants) Regulations, 2018
Regulatory Filings Classification · 95% confidence The document is a letter addressed to stock exchanges regarding compliance under Regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018. It includes a certificate from the Registrar & Share Transfer Agent confirming compliance for the quarter ended December 31, 2020. The document is short (1732 characters) and serves as a compliance certificate submission rather than a financial report or detailed filing. It does not contain financial statements, management discussion, or detailed report content. It is a regulatory compliance communication to stock exchanges, fitting best under Regulatory Filings (RNS) as a general regulatory announcement and compliance document.
2021-01-12 English
Trading Window
Regulatory Filings Classification · 95% confidence The document is a notice regarding the closure of the trading window in compliance with SEBI (Prohibition of Insider Trading) Regulations, 2015. It informs the stock exchanges about the trading window closure period around the announcement of financial results for the quarter ending December 31, 2020. The document is short (1631 characters) and serves as an announcement related to insider trading compliance rather than containing any financial data or detailed report. It does not contain financial statements or detailed analysis, nor is it a report itself. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2020-12-31 English

Browse filings by year

12 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.